Article 2018-02-06T17:27:34+00:00

Shafrin in eyeforpharma: Value-based Pricing’s Time Has Come, and It’s Here to Stay

In “The Price of Everything and the Value of Nothing,” PHE Senior Research Economist Jason Shafrin talks prices, politics, and the problem of monopolies with eyeforpharma’s Hugh Gosling.

To read the complete article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.